need major help with cycle

[kracker76]

i want to start a Igf-1 lr3/ghr p-2 cycle and i have no idea what this requiers. i have done 2 test cycles in the past but just recently foub out about this stuff and am lost. need to know about dose,does it come as liquid or require reconstitution? in refrence to arr test type.

[ScotchGuard]

I started with 2iu/ed of HGH and increased 1iu/10days. Go slow HGH cycle should be at least 6 months and better if it was a year. For me, I use IGF-lr3 perpetually. I don't cycle it. I take 50mcg every other day (if I'm training really hard) to 50mcg every 3rd day. You can keep this up for a long time. The break gives your body's IGF receptors a chance to reset so they can continue to absorb IGF. I tend to be more conservative in my dosage. It seems the more popular way to take IGF would be to pin 80mcg to 100mcg everyday for 30days and take 30days off. I'm not a fan of this dosing regiment. I think it is too aggressive. It will grow guts and muscles.

[bigpapabuff]

I started with 2iu/ed of HGH and increased 1iu/10days. Go slow HGH cycle should be at least 6 months and better if it was a year. For me, I use IGF-lr3 perpetually. I don't cycle it. I take 50mcg every other day (if I'm training really hard) to 50mcg every 3rd day. You can keep this up for a long time. The break gives your body's IGF receptors a chance to reset so they can continue to absorb IGF. I tend to be more conservative in my dosage. It seems the more popular way to take IGF would be to pin 80mcg to 100mcg everyday for 30days and take 30days off. I'm not a fan of this dosing regiment. I think it is too aggressive. It will grow guts and muscles.

very good information, thank you. I have been interested in trying this for some time now, and am trying to decide between this or sarms. Everything I have seen talks about the 30 days on and 30 days off method, glad I saw your post, and would definitely give your method a chance first. Thanks for the info. Did you get your peptides from arr as well?

[kracker76]

what about the ghrp-2??????

[ScotchGuard]

Take a look at the study done at Tulane on older women. They were taking 1mcg per kg. Looks like the stuff works. For healthy adult males the start dosage was about 2mcg to 3mcg per kg of body weight. Something like this, take it slow you'll never regret it.

ABSTRACT
Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.

Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.

Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA. [email protected]

We test the interlinked hypotheses that in healthy older adults: 1). i.v. injection of GH-releasing peptide-2 (GHRP-2) and GHRH synergizes more in aging women than men; 2). sc infusion of both GHRP-2 (1 microg/kg.h = 1) and GHRH (1, 3, or 10) for 24 h augments GH secretion more than either agonist alone; and 3). continuous sc delivery of GHRP-2 (1) for 30 d stimulates daily GH secretion and IGF-I, IGF-binding protein-3 (IGFBP-3), and IGFBP-5. Acute two-peptide synergy was 3-fold greater in young (n = 16) than older volunteers (n = 17; P < 0.025) and was 2.3-fold higher in elderly women than men (P < 0.025). The 24-h infusion of GHRP-2 (1) combined with GHRH (3 or 10) in men and with GHRH (10) in women drove GH secretion more than GHRH alone (P <or= 0.024). In the entire cohort (n = 11), GHRP-2/GHRH (1/10) stimulated GH secretion more than either GHRP-2 (1; P = 0.021) or GHRH (10; P = 0.012). The 30-d delivery of GHRP-2 (1; n = 17 subjects): 1). stimulated pulsatile, rhythmic, and entropic GH secretion by more than 3-fold on d 1 and more than 1.8-fold on d 14 and 30 (each P < 0.001 vs. saline); 2). elevated IGF-I to a stable plateau on d 1, 14, and 30 (P < 0.025 vs. baseline); and 3). increased IGFBP-3 (P < 0.01) and IGFBP-5 (P < 0.025) on d 14 and/or 30. Safety screening tests remained normal. In summary, in healthy elderly women and men: 1). acute synergy of GHRP-2 and GHRH is greater in the female; 2). 24-h combined GHRP-2 and GHRH drive is more effective than either agonist alone; and 3). 30-d stimulation with GHRP-2 sustains a physiologically activated somatotropic axis. We conclude that age, gender, stimulus duration, and secretagogue combination determine acute, intermediate, and extended responses of the somatotropic axis in the older adult.